New Research Presented at San Antonio

bctt on January 2, 2019

The San Antonio Breast Cancer Symposium is a key breast cancer conference that takes place each year. Researchers often use this meeting to report results from large studies that have the potential to change the standard of care for breast cancer treatment.

Below you will find links to some of the findings relevant to women and men living with metastatic breast cancer.

Insights into Treatment Resistance

bctt on September 1, 2018

Over time, cancer cells often stop responding to the treatment that is keeping the tumor in check. This is called treatment resistance.

Below you will find three articles that address different aspects of treatment resistance. The first article describes research looking into the genetics of cells that become resistant. The goal is to use this information to identify new treatments. Following that are articles about treatment resistance in ER+ breast tumors and the relationship between HER2 mutations and resistance to hormone therapies.

Looking for more information? There’s an entire journal devoted to the topic: Cancer Drug Resistance. You can find it here: CDR Journal.

Speaking Out on Inflammatory Breast Cancer

bctt on September 1, 2018

Inflammatory breast cancer (IBC) is a rare, aggressive form of breast cancer. You can learn more about IBC on these websites:
Inflammatory Breast Cancer Research Foundation
Inflammatory Breast Cancer Network Foundation
MD Anderson Inflammatory Breast Cancer Research Program & Clinic

This month we feature three stories by women who were diagnosed with metastatic IBC.

CRISPR & Cancer

bctt on August 1, 2018

CRISPR is short for Clustered Regularly Interspaced Short Palindromic Repeats. And if you follow science news, you’ve been hearing it a lot lately. What do you need to know about CRISPR and cancer?

First, we’ve got a Wired video that explains CRISPR in 5 different ways, so you, too, will know what everyone’s talking about. Next up is an article on how CRISPR might be used to treat cancer. And after that, there’s two articles on the recent finding that CRISPR results in more DNA damage than initially thought–and may cause cancer.